Ethics approval received for the Acarbose Cardiovascular Evaluation (ACE) trial


The ACE trial has received ethics approval from the Oxford Tropical Research Ethics Committee (OXTREC). This independent body, based at Oxford University, specializes in the review of trials which do not recruit in Europe.

The trial now proceeds into full centre activation mode with a target of "First Patient First Visit" in December 2008. The trial aims to recruit 7500 IGT patients at 150 centres in the People's Republic of China.